The Medicines Company – Strategy, SWOT and Corporate Finance Report
- Pages: 53
- Published: June 2019
- Report Code: MLPH31280FSA
The Medicines Company – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company
Key Highlights
The Medicines Company (TMC) is a biopharmaceutical company that focuses on developing and commercializing novel therapies to address the unmet medical need for atherosclerotic cardiovascular disease (ASCVD). It is investigating a RNA interference (RNAi) therapeutic, inclisiran, for the treatment of ASCVD. Its inclisiran exclusively inhibits production of proprotein convertase subtilisin or kexin type 9 (PCSK9), a key protein that controls LDL-cholesterol (LDL-C) levels. TMC is also evaluating an investigational candidate for the treatment of homozygous familial hypercholesterolemia (HoFH). The company holds the rights to develop, manufacture, and commercialize inclisiran through a license agreement with Alnylam Pharmaceuticals Inc. TMC is headquartered in New Jersey, the US.
Scope
Detailed information on The Medicines Company required for business and competitor intelligence needs
A study of the major internal and external factors affecting The Medicines Company in the form of a SWOT analysis
An in-depth view of the business model of The Medicines Company including a breakdown and examination of key business segments
News about The Medicines Company, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of The Medicines Company and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess The Medicines Company as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on The Medicines Companys business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Sanofi
RegenxBio Inc
Regeneron Pharmaceuticals Inc
Merck & Co Inc
Ionis Pharmaceuticals Inc
Gemphire Therapeutics Inc
Esperion Therapeutics Inc
Amgen Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.